Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

CONTRIBUTING WRITER

Deepak Balak, MD, MSc
Erasmus MC, Department of Dermatology
Utrecht, Netherlands

Dr. Balak works as a dermatologist at the Department of Dermatology and Allergology of the University Medical Center Utrecht in Utrecht, the Netherlands, where he combines patient care with teaching responsibilities and research. His clinical interests are centered on the impact and management of inflammatory and autoimmune diseases. His scientific interests include translational medicine, clinical drug development, and evaluation in the field of chronic immune-mediated inflammatory skin diseases, such as psoriasis. As a 2019 Fellow, he will study with Dr. Alice Gottlieb at the Mount Sinai Hospital in New York, New York and attend the European Academy of Dermatology and Venereology Congress.

Last Updated: Nov 20, 2019

Latest news

March 30, 2021
Learn how psoriasis severity is currently measured and why a change is necessary, how IPC organized the Delphi process that was used to redefine severity classification, implications and effects the output has on psoriasis treatment providers and psoriasis patients, and ultimately how patients will benefit from this endeavor.
March 29, 2021
Janssen Pharmaceutical Companies of Johnson & Johnson published the long-term data of the third phase of the DISCOVER-2a study.
March 28, 2021
Sun Pharmaceutical Industries Inc. announces results from their five-year Phase-3 efficacy and safety clinical trial for ILUMYA®(tildrakizumab-asmn) based on a pooled analysis of the ReSURFACE 1 and ReSURFACE 2 extension.
March 17, 2021
Update on the PsoProtect Registry. PsoProtect is a global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis. Data set currently includes 1002 cases.
  More News

We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.
OK